Earnings · China A-shares
Beijing Beilu Pharmaceutical Co., Ltd. Class A (300016) earnings
Beijing Beilu Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +157.83% year on year, +200.55% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +6.04% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +157.83%
- Excl. one-offs YoY
- +200.55%
- Net profit QoQ
- -1.80%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +6.04% | — |
| 3 days | +6.04% | — |
| 7 days | +7.75% | — |
| 14 days | +0.53% | — |
Report history
Over the last 8 reports, net profit grew year on year in 8 of them. The stock rose in the 3 trading days after 5 of 8 reports (average +0.53%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥113.90M | +157.83% | +200.55% | +21.30% | 0.20 | 4.76% | +6.04% | — | — |
| 2026 interim report | 2026-08-25 | ¥79.75M | +166.13% | +146.93% | +15.26% | 0.14 | 3.40% | -4.00% | -10.42% | -4.40% |
| 2026 Q1 report | 2026-04-29 | ¥44.98M | +209.36% | +203.47% | +13.33% | 0.08 | 1.97% | +5.46% | -17.14% | -18.09% |
| 2025 annual report | 2026-04-22 | ¥92.73M | +579.29% | +184.21% | +22.54% | 0.18 | 4.88% | -5.30% | -19.14% | -20.73% |
| 2025 Q3 report | 2025-10-29 | ¥44.18M | +81.10% | +33.53% | +19.59% | 0.09 | 2.46% | +3.38% | -5.25% | -1.78% |
| 2025 interim report | 2025-08-26 | ¥29.97M | +53.35% | +55.58% | +23.27% | 0.06 | 1.78% | -6.89% | -18.74% | -20.41% |
| 2025 Q1 report | 2025-04-25 | ¥14.54M | +26.13% | +14.34% | +36.23% | 0.03 | 0.87% | +2.58% | +40.90% | +37.66% |
| 2024 annual report | 2025-04-18 | ¥13.65M | +119.02% | +120.27% | +10.42% | 0.03 | 0.83% | +3.00% | +34.78% | +31.87% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.